Literature DB >> 24478108

A novel homozygous splicing mutation in PSAP gene causes metachromatic leukodystrophy in two Moroccan brothers.

Laura Siri1, Andrea Rossi, Federica Lanza, Raffaella Mazzotti, Anna Costa, Marina Stroppiano, Alberto Gaiero, Amnon Cohen, Roberta Biancheri, Mirella Filocamo.   

Abstract

Prosaposin (PSAP) gene mutations, affecting saposin B (Sap-B) domain, cause a rare metachromatic leukodystrophy (MLD) variant in which arylsulfatase A (ARSA) activity is normal. To date, only 10 different PSAP mutations have been associated with a total of 18 unrelated MLD patients worldwide. In this study, we report for the first time a family with Moroccan origins in which the proband, presenting with a late-infantile onset of neurological involvement and a brain MRI with the typical tigroid MLD pattern, showed normal values of ARSA activity in the presence of an abnormal pattern of urinary sulfatides. In view of these findings, PSAP gene was analyzed, identifying the newly genomic homozygous c.909 + 1G > A mutation occurring within the invariant GT dinucleotide of the intron 8 donor splice site. Reverse transcriptase-polymerase chain reaction (RT-PCR), showing the direct junction of exon 7 to exon 9, confirmed the skipping of the entire exon 8 (p.Gln260_Lys303) which normally contains two cysteine residues (Cys271 and Cys265) involved in disulfide bridges. Our report provides further evidence that phenotypes of patients with Sap-B deficiency vary widely depending on age of onset, type, and severity of symptoms. Awareness of this rare MLD variant is crucial to prevent delayed diagnosis or misdiagnosis and to promptly provide an accurate genetic counseling, including prenatal diagnosis, to families.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24478108     DOI: 10.1007/s10048-014-0390-4

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  14 in total

1.  Standardizing mutation nomenclature: why bother?

Authors:  Johan T den Dunnen; Mark H Paalman
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878

2.  The assay of arylsulphatases A and B in human urine.

Authors:  H BAUM; K S DODGSON; B SPENCER
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

3.  The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy.

Authors:  X L Zhang; M A Rafi; G DeGala; D A Wenger
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

4.  A variant form of metachromatic leukodystrophy without arylsulfatase deficiency.

Authors:  A F Hahn; B A Gordon; G G Hinton; J J Gilbert
Journal:  Ann Neurol       Date:  1982-07       Impact factor: 10.422

Review 5.  Sphingolipid activator protein B deficiency: report of 9 Saudi patients and review of the literature.

Authors:  Zuhair N Al-Hassnan; Hesham Al Dhalaan; Zoltan Patay; Eissa Faqeih; Mohammed Al-Owain; Adel Al-Duraihem; Mohammed Faiyaz-Ul-Haque
Journal:  J Child Neurol       Date:  2009-12       Impact factor: 1.987

6.  Human urinary sulfatides in patients with sulfatidosis (metachromatic leukodystrophy).

Authors:  M Philippart; L Sarlieve; C Meurant; L Mechler
Journal:  J Lipid Res       Date:  1971-07       Impact factor: 5.922

7.  Analysis of a splice-site mutation in the sap-precursor gene of a patient with metachromatic leukodystrophy.

Authors:  M Henseler; A Klein; M Reber; M T Vanier; P Landrieu; K Sandhoff
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

8.  Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations.

Authors:  Ladislav Kuchar; Jana Ledvinová; Martin Hrebícek; Helena Mysková; Lenka Dvoráková; Linda Berná; Petr Chrastina; Befekadu Asfaw; Milan Elleder; Margret Petermöller; Heidi Mayrhofer; Martin Staudt; Ingeborg Krägeloh-Mann; Barbara C Paton; Klaus Harzer
Journal:  Am J Med Genet A       Date:  2009-02-15       Impact factor: 2.802

9.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

10.  Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice.

Authors:  Ying Sun; David P Witte; Huimin Ran; Matt Zamzow; Sonya Barnes; Hua Cheng; Xianlin Han; Michael T Williams; Matthew R Skelton; Charles V Vorhees; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2008-05-14       Impact factor: 6.150

View more
  1 in total

Review 1.  Clinical and Genetic Characteristics of Leukodystrophies in Africa.

Authors:  Mutaz Amin; Liena Elsayed; Ammar Eltahir Ahmed
Journal:  J Neurosci Rural Pract       Date:  2017-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.